utahmedical8k.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934



Date of Report (date of earliest event reported): May 6, 2011


Commission File No. 001-12575


UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
   
   
UTAH
87-0342734
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
   
   
   
7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices

Registrant's telephone number:     (801) 566-1200
 
 
 


ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS


On May 6, 2011 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:

Elected Ernst G. Hoyer as a director of the Company:
  
For   2,644,531
Withheld   90,998
Broker Non-Votes  544,656
  
       
Elected James H. Beeson as a director of the Company:
    
 For  2,652,244
Withheld  83,285
Broker Non-Votes  544,656
  
       
Ratified the selection of Jones, Simkins P.C. as the Company’s independent public accounting firm for the year ended December 31, 2011:
For  3,244,036
Against  14,717
Abstentions  21,432
  
       
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
For  2,697,042
Against  25,619
Abstentions  12,868
  
       
Indicated, on an advisory basis, their preference for annual shareholder votes on executive compensation:
1 Year  2,367,054
2 Year  44,313
3 Year  293,886
Abstentions  30,277


 
 
 

 
SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
   
Date:         5/10/2011
By:      /s/ Kevin L. Cornwell
 
Kevin L. Cornwell
 
CEO